vs

Side-by-side financial comparison of Genie Energy Ltd. (GNE) and Viridian Therapeutics, Inc.\DE (VRDN). Click either name above to swap in a different company.

Genie Energy Ltd. is the larger business by last-quarter revenue ($138.3M vs $70.6M, roughly 2.0× Viridian Therapeutics, Inc.\DE). Genie Energy Ltd. runs the higher net margin — 4.9% vs -49.0%, a 53.9% gap on every dollar of revenue. On growth, Viridian Therapeutics, Inc.\DE posted the faster year-over-year revenue change (81958.1% vs 23.6%).

Genie Energy Ltd. is an American energy company headquartered in Newark, New Jersey. It is a holding company comprising Genie Retail Energy, Genie Retail Energy International, Genie Energy Services, and Genie Energy Oil and Gas. Michael Stein is the Chief Executive Officer, Genie Energy Ltd.

Viridian Therapeutics is a clinical-stage biotechnology firm developing novel disease-modifying therapies for rare, serious autoimmune and inflammatory diseases. Its lead pipeline candidate targets thyroid eye disease, a debilitating orbital disorder, with primary market focus on North America and Europe.

GNE vs VRDN — Head-to-Head

Bigger by revenue
GNE
GNE
2.0× larger
GNE
$138.3M
$70.6M
VRDN
Growing faster (revenue YoY)
VRDN
VRDN
+81934.5% gap
VRDN
81958.1%
23.6%
GNE
Higher net margin
GNE
GNE
53.9% more per $
GNE
4.9%
-49.0%
VRDN

Income Statement — Q3 FY2025 vs Q3 FY2025

Metric
GNE
GNE
VRDN
VRDN
Revenue
$138.3M
$70.6M
Net Profit
$6.7M
$-34.6M
Gross Margin
21.7%
Operating Margin
5.0%
-56.7%
Net Margin
4.9%
-49.0%
Revenue YoY
23.6%
81958.1%
Net Profit YoY
-33.9%
54.9%
EPS (diluted)
$0.26

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
GNE
GNE
VRDN
VRDN
Q3 25
$138.3M
$70.6M
Q2 25
$105.3M
Q1 25
$136.8M
Q4 24
$102.9M
Q3 24
$111.9M
Q2 24
$90.7M
Q1 24
$119.7M
Q4 23
$104.9M
Net Profit
GNE
GNE
VRDN
VRDN
Q3 25
$6.7M
$-34.6M
Q2 25
$2.8M
Q1 25
$10.3M
Q4 24
$-15.3M
Q3 24
$10.2M
Q2 24
$9.6M
Q1 24
$8.1M
Q4 23
$-24.5M
Gross Margin
GNE
GNE
VRDN
VRDN
Q3 25
21.7%
Q2 25
22.3%
Q1 25
27.3%
Q4 24
32.5%
Q3 24
33.9%
Q2 24
36.8%
Q1 24
28.2%
Q4 23
32.0%
Operating Margin
GNE
GNE
VRDN
VRDN
Q3 25
5.0%
-56.7%
Q2 25
1.9%
Q1 25
9.4%
Q4 24
-20.2%
Q3 24
10.4%
Q2 24
11.6%
Q1 24
8.2%
Q4 23
-32.6%
Net Margin
GNE
GNE
VRDN
VRDN
Q3 25
4.9%
-49.0%
Q2 25
2.7%
Q1 25
7.5%
Q4 24
-14.9%
Q3 24
9.1%
Q2 24
10.6%
Q1 24
6.8%
Q4 23
-23.4%
EPS (diluted)
GNE
GNE
VRDN
VRDN
Q3 25
$0.26
Q2 25
$0.11
Q1 25
$0.40
Q4 24
$-0.58
Q3 24
$0.38
Q2 24
$0.36
Q1 24
$0.30
Q4 23
$-0.90

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
GNE
GNE
VRDN
VRDN
Cash + ST InvestmentsLiquidity on hand
$109.8M
$490.9M
Total DebtLower is stronger
Stockholders' EquityBook value
$198.8M
$503.0M
Total Assets
$394.1M
$577.1M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
GNE
GNE
VRDN
VRDN
Q3 25
$109.8M
$490.9M
Q2 25
$106.0M
Q1 25
$118.3M
Q4 24
$110.1M
Q3 24
$141.8M
Q2 24
$126.8M
Q1 24
$106.9M
Q4 23
$111.4M
Stockholders' Equity
GNE
GNE
VRDN
VRDN
Q3 25
$198.8M
$503.0M
Q2 25
$197.0M
Q1 25
$198.0M
Q4 24
$190.5M
Q3 24
$211.1M
Q2 24
$202.1M
Q1 24
$192.9M
Q4 23
$197.2M
Total Assets
GNE
GNE
VRDN
VRDN
Q3 25
$394.1M
$577.1M
Q2 25
$383.1M
Q1 25
$384.4M
Q4 24
$371.3M
Q3 24
$341.7M
Q2 24
$322.8M
Q1 24
$328.3M
Q4 23
$330.6M

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
GNE
GNE
VRDN
VRDN
Operating Cash FlowLast quarter
$13.9M
$-84.6M
Free Cash FlowOCF − Capex
$-84.7M
FCF MarginFCF / Revenue
-120.1%
Capex IntensityCapex / Revenue
0.2%
Cash ConversionOCF / Net Profit
2.07×
TTM Free Cash FlowTrailing 4 quarters

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
GNE
GNE
VRDN
VRDN
Q3 25
$13.9M
$-84.6M
Q2 25
$1.1M
Q1 25
$15.3M
Q4 24
$13.0M
Q3 24
$24.4M
Q2 24
$20.4M
Q1 24
$12.9M
Q4 23
$10.5M
Free Cash Flow
GNE
GNE
VRDN
VRDN
Q3 25
$-84.7M
Q2 25
Q1 25
$13.6M
Q4 24
Q3 24
$21.9M
Q2 24
$20.1M
Q1 24
$11.7M
Q4 23
FCF Margin
GNE
GNE
VRDN
VRDN
Q3 25
-120.1%
Q2 25
Q1 25
9.9%
Q4 24
Q3 24
19.6%
Q2 24
22.1%
Q1 24
9.8%
Q4 23
Capex Intensity
GNE
GNE
VRDN
VRDN
Q3 25
0.2%
Q2 25
Q1 25
1.3%
Q4 24
Q3 24
2.2%
Q2 24
0.4%
Q1 24
1.0%
Q4 23
Cash Conversion
GNE
GNE
VRDN
VRDN
Q3 25
2.07×
Q2 25
0.40×
Q1 25
1.49×
Q4 24
Q3 24
2.39×
Q2 24
2.12×
Q1 24
1.59×
Q4 23

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

GNE
GNE

Sales Channel Directly To Consumer$108.8M79%
Sales Channel Through Intermediary$23.5M17%
Genie Renewables GREW$6.0M4%

VRDN
VRDN

Segment breakdown not available.

Related Comparisons